Pfizer and Jeil to extend distribution agreement with Lyrica

Published: 2005-05-04 06:58:00

Updated: 2005-05-04 06:58:00

The distribution agreement made between Pfizer Korea and Jeil Pharm. Co. will expire on May 31, 2005 and therefore mutually agreed to extend it on April 28 for an ongoing distribution of Lipitor and Neurontin in addition to a new epileptic drug, Lyrica effective from June 1 this year.

Lipitor ...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK